ImmunOs Therapeutics picks up Series B
ImmunOs Therapeutics AG, a biopharmaceutical company, has raised $74 million in Series B financing.
ImmunOs Therapeutics AG, a biopharmaceutical company, has raised $74 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination